Yosuke Shimodaira
Overview
Explore the profile of Yosuke Shimodaira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okita M, Takenaka K, Hirai F, Ashizuka S, Iijima H, Bamba S, et al.
J Gastroenterol
. 2025 Feb;
PMID: 39953247
Background: Small bowel (SB) lesions in Crohn's disease (CD) are often asymptomatic despite being highly active. Fecal calprotectin (FC) is the most widely used biomarker of CD activity, but its...
2.
Fukuda S, Watanabe K, Kubota D, Yamamichi N, Takahashi Y, Watanabe Y, et al.
J Gastroenterol
. 2025 Feb;
PMID: 39928142
Background: Given the high prevalence of esophageal adenocarcinoma and Barrett's esophagus (BE), a precancerous lesion, among males, it is important to understand the characteristics of BE by sex to develop...
3.
Watanabe K, Tsuji T, Matsuzawa H, Saruta Y, Shimodaira Y, Iijima K
J Gastroenterol Hepatol
. 2024 Dec;
40(3):609-617.
PMID: 39690954
Background And Aim: Few prediction scores for Clostridioides difficile infection (CDI), a potentially life-threatening nosocomial diarrhea, combine high accuracy with simplicity. A simple prediction score for routine clinical practice is...
4.
Fukuda S, Watanabe K, Fujimori S, Komatsu T, Yoshida T, Kuramitsu T, et al.
Tohoku J Exp Med
. 2024 Oct;
PMID: 39384374
No abstract available.
5.
Alatan H, Liang S, Shimodaira Y, Wu X, Hu X, Wang T, et al.
Front Immunol
. 2024 Sep;
15:1407620.
PMID: 39346901
Introduction: Major depressive disorder is a condition involving microbiota-gut-brain axis dysfunction. Increasing research aims to improve depression through gut microbiota regulation, including interventions such as probiotics, prebiotics, and fecal microbiota...
6.
Kodama S, Watanabe K, Shimodaira Y, Fukuda S, Yoshida T, Saruta Y, et al.
Esophagus
. 2024 Aug;
21(4):552-562.
PMID: 39158677
Background: The incidence of esophageal adenocarcinoma has recently increased in Asia, including Japan. A system to identify individuals at high risk for Barrett's esophagus (BE), a pre-cancerous condition of esophageal...
7.
Fukuda S, Watanabe K, Kubota D, Yamamichi N, Takahashi Y, Watanabe Y, et al.
J Gastroenterol
. 2024 Aug;
59(10):887-895.
PMID: 39150527
Background: The cancer risk for each length of Barrett's esophagus (BE) in Japanese is unknown. This nationwide, multi-institutional study aims to clarify the cancer risk by length of BE in...
8.
Shimodaira Y, Fukuda S, Okubo R, Onochi K, Iijima K
Cureus
. 2024 May;
16(4):e57941.
PMID: 38738157
A patient who received a loop sigmoid colostomy was diagnosed with ulcerative colitis (pancolitis type) and treated with infliximab. Thereafter, he relapsed with intestinal inflammation only on the rectal side...
9.
Iijima K, Watanabe K, Shimodaira Y, Koizumi S, Fukuda S, Yoshida T, et al.
Tohoku J Exp Med
. 2024 Apr;
263(2):161-168.
PMID: 38658347
The long-term impact of the coronavirus disease 2019 (COVID-19) pandemic on the disruption of gastrointestinal cancer diagnoses remains unclear. This study investigated the actual impact on esophagogastric cancer (EGC) and...
10.
Makuuchi M, Kakuta Y, Umeno J, Fujii T, Takagawa T, Ibuka T, et al.
J Gastroenterol
. 2024 Apr;
59(6):468-482.
PMID: 38589597
Background: This study evaluated the effectiveness of NUDT15 codon 139 genotyping in optimizing thiopurine treatment for inflammatory bowel disease (IBD) in Japan, using real-world data, and aimed to establish genotype-based...